TY  - JOUR
AU  - Ruiz-Antorán, Belén
AU  - Sancho-López, Aránzazu
AU  - Torres, Ferrán
AU  - Moreno-Torres, Víctor
AU  - de Pablo-López, Itziar
AU  - García-López, Paulina
AU  - Abad-Santos, Francisco
AU  - Rosso-Fernández, Clara M
AU  - Aldea-Perona, Ana
AU  - Montané, Eva
AU  - Aparicio-Hernández, Ruth M
AU  - Llop-Rius, Roser
AU  - Pedrós, Consuelo
AU  - Gijón, Paloma
AU  - Hernández-Carballo, Carolina
AU  - Pedrosa-Martínez, María J
AU  - Rodríguez-Jiménez, Consuelo
AU  - Prada-Ramallal, Guillermo
AU  - Cabrera-García, Lourdes
AU  - Aguilar-García, Josefa A
AU  - Sanjuan-Jimenez, Rocío
AU  - Ortiz-Barraza, Evelyn I
AU  - Sánchez-Chica, Enrique
AU  - Fernández-Cruz, Ana
AU  - TOCICOV-study group
PY  - 2020
DO  - 10.1007/s40121-020-00373-8
SN  - 2193-8229
UR  - https://hdl.handle.net/10668/26780
T2  - Infectious diseases and therapy
AB  - We aimed to determine the impact of tocilizumab use on severe COVID-19 (coronavirus disease 19) pneumonia mortality. We performed a multicentre retrospective cohort study in 18 tertiary hospitals in Spain from March to April 2020. Consecutive patients...
LA  - en
KW  - COVID-19
KW  - Mortality
KW  - SARS-CoV-2
KW  - Steroids
KW  - Tocilizumab
TI  - Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.
TY  - research article
VL  - 10
ER  -